RNA-coded antibody
US-11421038-B2 · Aug 23, 2022 · US
This page is not indexed by search engines while we improve data quality.
Hoerr Ingmar patents
Hoerr Ingmar holds 4 patents in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 4 |
| Recent patents | 0 |
| First publication | Jan 5, 2016 |
| Latest publication | Aug 23, 2022 |
Filing trend
Year-over-year patent counts for this assignee.
Recent patents
Latest publications where this party is an assignee.
Nucleic acid comprising GlXmGn as an immune-stimulating agent/adjuvant
US-10441653-B2 · Oct 15, 2019 · US
Pharmaceutical composition containing a stabilised mRNA optimised for translation in its coding regions
US-10188748-B2 · Jan 29, 2019 · US
Nucleic acids comprising formula (NuGlXmGnNv)a and derivatives thereof as immunostimulating agent/adjuvant
US-9226959-B2 · Jan 5, 2016 · US
Notable patents
Representative or frequently cited publications from precomputed assignee stats.
RNA-coded antibody
US-11421038-B2 · Aug 23, 2022 · US
Nucleic acid comprising GlXmGn as an immune-stimulating agent/adjuvant
US-10441653-B2 · Oct 15, 2019 · US
Pharmaceutical composition containing a stabilised mRNA optimised for translation in its coding regions
US-10188748-B2 · Jan 29, 2019 · US
Nucleic acids comprising formula (NuGlXmGnNv)a and derivatives thereof as immunostimulating agent/adjuvant
US-9226959-B2 · Jan 5, 2016 · US
Technology areas
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Human Necessities | 4 |
| Chemistry & Metallurgy | 4 |
| Cross-Sectional Technologies | 3 |
| Physics | 1 |